WebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and … WebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2024, as a material inducement to their …
CYTK Stock Price Cytokinetics Inc. Stock Quote (U.S.: Nasdaq ...
WebMar 31, 2024 · Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised. Careers; Contact Us; Our Focus. We are developing … WebCytokinetics eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per … how much money do tower climbers make
Is a Surprise Coming for Cytokinetics (CYTK) This Earnings Season?
WebFeb 24, 2024 · Cytokinetics press release (CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51.Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M.Cash, cash equivalents and … WebFeb 24, 2024 · Cytokinetics press release (NASDAQ: CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51. Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M. Cash, cash equivalents and investments totaled $623.7 million... WebApr 13, 2024 · During the same quarter in the previous year, the firm posted ($0.36) EPS. Research analysts predict that Cytokinetics, Incorporated will post -4.4 earnings per share for the current fiscal year. Insiders Place Their Bets. In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday ... how do i print a goodrx card